Cargando…

The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder

OBJECTIVE: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampaio, Thiago, Lima, Cristiane, Corregiari, Fabio, Bernik, Marcio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111354/
https://www.ncbi.nlm.nih.gov/pubmed/27798711
http://dx.doi.org/10.1590/1516-4446-2015-1721
_version_ 1783513273015992320
author Sampaio, Thiago
Lima, Cristiane
Corregiari, Fabio
Bernik, Marcio
author_facet Sampaio, Thiago
Lima, Cristiane
Corregiari, Fabio
Bernik, Marcio
author_sort Sampaio, Thiago
collection PubMed
description OBJECTIVE: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in the central nervous system (CNS) which might be explained by suppression of defensive fixed action patterns. Previous studies have proposed that higher baseline 5-HT concentration and slow decrease in concentration during drug treatment of OCD were predictors of good clinical response to 5-HT reuptake inhibitors. The objective of this study was to investigate whether pre-treatment platelet rich plasma (PRP) 5-HT concentration is associated with latency of treatment response and final response to an ERP protocol for obsessive-compulsive disorder (OCD). METHODS: Thirty adult and treatment-free OCD patients were included in an 8-week, 16-session ERP protocol. 5-HT concentration was determined at baseline and after treatment. Patients with a reduction ≥30% on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at the end of ERP were defined as responders. RESULTS: A positive correlation between baseline 5-HT concentration and reduction of symptoms on the Y-BOCS was observed after 4 weeks. Baseline 5-HT concentration was not correlated with clinical response after 8 weeks of ERP, possibly due to the similar though delayed clinical response of patients with lower (compared to those with higher) baseline 5-HT concentration. Patients with higher 5-HT baseline concentration also showed more improvement in depressive symptoms with treatment. CONCLUSION: The present results partially support the hypothesis of a stress endurance effect of 5-HT in OCD patients. According to the literature, fast onset responders possibly have more or larger 5-HT containing neurons, higher endogenous 5-HT synthesis or lower monoamine oxidase activity; all these hypotheses remain to be investigated.
format Online
Article
Text
id pubmed-7111354
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Associação Brasileira de Psiquiatria
record_format MEDLINE/PubMed
spelling pubmed-71113542020-04-02 The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder Sampaio, Thiago Lima, Cristiane Corregiari, Fabio Bernik, Marcio Braz J Psychiatry Original Article OBJECTIVE: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in the central nervous system (CNS) which might be explained by suppression of defensive fixed action patterns. Previous studies have proposed that higher baseline 5-HT concentration and slow decrease in concentration during drug treatment of OCD were predictors of good clinical response to 5-HT reuptake inhibitors. The objective of this study was to investigate whether pre-treatment platelet rich plasma (PRP) 5-HT concentration is associated with latency of treatment response and final response to an ERP protocol for obsessive-compulsive disorder (OCD). METHODS: Thirty adult and treatment-free OCD patients were included in an 8-week, 16-session ERP protocol. 5-HT concentration was determined at baseline and after treatment. Patients with a reduction ≥30% on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at the end of ERP were defined as responders. RESULTS: A positive correlation between baseline 5-HT concentration and reduction of symptoms on the Y-BOCS was observed after 4 weeks. Baseline 5-HT concentration was not correlated with clinical response after 8 weeks of ERP, possibly due to the similar though delayed clinical response of patients with lower (compared to those with higher) baseline 5-HT concentration. Patients with higher 5-HT baseline concentration also showed more improvement in depressive symptoms with treatment. CONCLUSION: The present results partially support the hypothesis of a stress endurance effect of 5-HT in OCD patients. According to the literature, fast onset responders possibly have more or larger 5-HT containing neurons, higher endogenous 5-HT synthesis or lower monoamine oxidase activity; all these hypotheses remain to be investigated. Associação Brasileira de Psiquiatria 2016-10-17 /pmc/articles/PMC7111354/ /pubmed/27798711 http://dx.doi.org/10.1590/1516-4446-2015-1721 Text en http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sampaio, Thiago
Lima, Cristiane
Corregiari, Fabio
Bernik, Marcio
The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
title The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
title_full The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
title_fullStr The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
title_full_unstemmed The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
title_short The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
title_sort putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111354/
https://www.ncbi.nlm.nih.gov/pubmed/27798711
http://dx.doi.org/10.1590/1516-4446-2015-1721
work_keys_str_mv AT sampaiothiago theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder
AT limacristiane theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder
AT corregiarifabio theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder
AT bernikmarcio theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder
AT sampaiothiago putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder
AT limacristiane putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder
AT corregiarifabio putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder
AT bernikmarcio putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder